PharmaCyte Biotech Inc (PMCB)

[Hotelier51]

Yikes....This Already Had Mice Trials...in 1998.

Injection of encapsulated CYP2B1-expressing cells into pre-established human pancreatic tumours in nude mice results in complete tumour regression in about 20% of animals and a significant antitumour effect in the remainder.

Löhr JM, Bago ZT, Bergmeister H, et al. Cell therapy using
microencapsulated 293 cells transfected with a gene contruct
expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-
arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study. J Mol Med 1999; 77: 393–98

THE LANCET • Vol 357 • May 19, 2001